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Dear Editor
Angiotensin-converting-enzyme inhibitors (ACE-I) and angiotensin-II receptor blockers
(ARB) have become progressively popular to treat hypertension due to their beneficial
effect in reducing morbidity and mortality. At the same time the rate of major noncardiac
surgical procedures is increasing and the use of these agents may pose challenges in
the perioperative setting. Intraoperative hypotension in the setting of ACE-I and ARBs
use has been reported in the literature[1]. However, the effect on ACE-I and ARB on
induction related hypotension has not been studied. Induction related hypotension
almost always occurs, is immediate and plateaus soon after due to increased volume
loading, vasopressor use and cardiovascular adaptation[2]. The question was raised
whether ACE-I or ARB continuation increases the risk of induction related intraoperative
hypotension within 15 minutes after general anesthesia in elective non-cardiac
surgeries.

WE conducted a retrospective-cohort-study among elective non-cardiac surgery
patients. The study was approved by the institutional review board and informed
consent was waived. 400 electronic medical records with patients who had an ACE-I or
ARB on their list of preoperative home medications were screened. Patients were
divided into two groups: continuation of ACE/ARB and discontinuation of ACE/ARB.
Patient who received regional anesthesia were excluded. Hypotension was defined as
either: systolic-BP <90 mm Hg or systolic-BP decrease of >20%.

349 patients were included for final analysis. The mean admission ASA-status was
2.7±0.5, age 65±11 years, and BMI 31±6.9 kg/m2. There were no statistically significant
changes between the ACE-I/ARB continuation and discontinuation group in terms of SBP
(p=0.853), DBP (p=0.357), MAP (p=0.782) and HR (p=0.220), figure 1. There were also
no significant differences in induction medication dose (propofol, fentanyl and rocuronium)
and pressor use (p=0.137). Hypotension (p<0.001) occurred equally in both groups over
15 minutes.
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Hollman et al[3] meta-analysis showed that continuation of ACE-Is/ARBs was associated
with increased risk of intraoperative hypotension up to 60 minutes after induction.
However, most included studies had a low sample size, pertains to a specific type of
surgery such as vascular, cardiac, or bariatric, and reported only small incidences of
hypotension. The heterogeneity was very high (I2=71%) and the results may not be
generalizable or reproducible in a larger patient population. Furthermore, no study looked
specifically for the effect on induction related hypotension. Despite intraoperative
hypotension was reported, the meta-analysis was unable to demonstrate an association
between perioperative ACE-I/ARB administration and mortality, MACE, CHF, AKI, or CVA.

The decision whether to continue or withhold ACE-I/ARB preoperatively in elective noncardiac surgeries is still controversial. Currently, the 2014 American College of
Cardiology/American Heart Association guidelines[4] state that it is reasonable to
continue therapy preoperatively, and if withheld, therapy may be reinstituted as soon as
clinically feasible.
The European Society of Cardiology/European Society of Anaesthesiology [5] bases its
recommendations on the indication for treatment with an ACE-I/ARB, recommending
discontinuation for 24-hours before surgery if prescribed for hypertension, and
continuation if prescribed for heart failure and left ventricular systolic dysfunction.

In conclusion the continuation of ACE-I/ARB on the day of surgery was not associated
with increased risk of intraoperative hypotension upon induction and within 15 minutes of
general anesthesia in elective non-cardiac surgeries. However, the risk of intraoperative
hypotension even after the induction phase with continuation of ACE/ARB still remains
controversial, and the current evidence has failed to correlate the impact of
intraoperative hypotension with adverse patient outcome. Our study adds another piece
of data into the discussion and we suggest that individual perioperative risk factors
should be considered before making the decision whether to continue or withhold ACEI/ARB. Discontinuation may be considered for patients at high risk for hypotension-related
complications, including patients with critical cardiovascular or cerebrovascular disease.
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Figure 1. Mean ± SEM Mean Arterial Pressure (MAP) measured pre-induction and at
six additional time points for 15 minutes post induction

